Suchergebnisse - Dexamethasone OR corticosteroid

PubPharm (236)

41

Recurrent painful ophthalmoplegic neuropathy: A report on the patient from the Romani population and 82-year-old patient

in: Vojnosanitetski Pregled | 2020

von Miletić-Drakulić Svetlana | Aleksić Dejan Zoran

42

Progressive fibrosing interstitial lung diseases : current practice in diagnosis and management

enthalten in: Current medical research and opinion | 2019

von Wijsenbeek, M. | Kreuter, M. | Olson, A. | +8

43

AL Amyloidosis for the Cardiologist and Oncologist : Epidemiology, Diagnosis, and Management

enthalten in: JACC. CardioOncology | 2019

von Witteles, R. | Liedtke, M.

44

Medication Use for Childhood Pneumonia at a Children's Hospital in Shanghai, China : Analysis of Pattern Mining Algorithms

enthalten in: JMIR medical informatics | 2019

von Tang, C. | Sun, H. | Xiong, Y. | +7

45

Systemic treatments for alopecia areata : A systematic review

enthalten in: The Australasian journal of dermatology | 2019

von Lai, V. | Chen, G. | Gin, D. | +1

46

Repository corticotropin injection in patients with advanced symptomatic sarcoidosis : retrospective analysis of medical records

enthalten in: Therapeutic advances in respiratory disease | 2019

von Chopra, I. | Qin, Y. | Kranyak, J. | +4

47

Musculoskeletal injections and alternative options : a practical guide to 'what, when and how?'

Erschienen: Boca Raton, FL, CRC Press, Taylor & Francis Group, [2019]

von Bhatia, M. | Paramesparan, K.

48

Treatment of non-infectious uveitis

Erschienen: Cham, Springer, [2019]

Springer eBooks, Medicine

von Lin, P. | Suhler, E.

49

Pharmacoeconomic review report : indication: for the treatment of adult patients with moderately to severely active ulcerative colitis (UC) with an inadequate response, loss of response, or intolerance to either conventional UC therapy or a tumour necrosis factor alpha inhibitorTofacitinib (Xeljanz) (Pfizer Canada Inc.)

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, March 2019

CADTH common drug review

Version: Final.

50

Pharmacoeconomic review report : Fluocinolone acetonide intravitreal implant (Iluvien) (Knight Therapeutics Inc.)

Erschienen: Ottawa (ON), Canadian Agency for Drugs and Technologies in Health, October 2019

CADTH common drug review

Version: final.